Camp4 Therapeutics (CAMP) Total Current Liabilities (2023 - 2026)
Camp4 Therapeutics (CAMP) posted Total Current Liabilities of $16.6 million for Q1 2026, up 7.15% sequentially from $15.5 million in Q4 2025, and up 158.1% YoY from $6.4 million in Q1 2025.
Camp4 Therapeutics (CAMP) Total Current Liabilities (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Total Current Liabilities for 4 years, with the latest figure at $16.6 million in Q1 2026.
- Quarterly Total Current Liabilities rose 158.1% year-over-year to $16.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.6 million (up 158.1% YoY) and the FY2025 annual result came in at $15.5 million, up 61.64% from the prior year.
- Total Current Liabilities rose to $16.6 million in Q1 2026 per CAMP's latest filing, from $15.5 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $16.6 million in Q1 2026 and troughed at $6.4 million in Q1 2025.
- A 4-year average of $10.4 million and a median of $8.8 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2025 and 2026: Total Current Liabilities plunged 33.19% in 2025, then surged 158.1% in 2026.
- Over 4 years, Total Current Liabilities stood at $7.8 million in 2023, then advanced by 22.94% to $9.6 million in 2024, then jumped by 61.64% to $15.5 million in 2025, then advanced by 7.15% to $16.6 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $16.6 million, $15.5 million, and $7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Camp4 Therapeutics | 282.48 Mn | 282.48 Mn | - | 19.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.14 Mn |
| Mar 31, 2026 | 16.62 Mn |
| Dec 31, 2025 | 15.51 Mn |
| Sep 30, 2025 | 7.90 Mn |
| Jun 30, 2025 | 7.34 Mn |
| Mar 31, 2025 | 6.44 Mn |
| Dec 31, 2024 | 9.60 Mn |
| Sep 30, 2024 | 11.83 Mn |
| Dec 31, 2023 | 7.81 Mn |